Orbactiv OverviewOritavancin (INN, also known as LY333328, Orbactiv) is a novel semisynthetic glycopeptide antibiotic for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin. In August 2014, the United States FDA approved oritavancin for treatment of skin infections. Contents 1 In vitro activity 1.1 Mechanism 2 Clinical trials 3 History 4 References 5 External links In vitro activ...
Read more Orbactiv Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Oritavancin
Recent Orbactiv Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Powder: 400mg/vial
- Powder, For Injection Solution, Lyophilized Powder: 1200 Mg.
NDC Database Records for Orbactiv: (2 results)Sorted by National Drug Code
- 65293-015 Orbactiv 400 mg Intravenous Injection, Powder, Lyophilized, for Solution by The Medicines Company
- 70842-140 Orbactiv 400 mg Intravenous Injection, Powder, Lyophilized, for Solution by Melinta Therapeutics, Inc.